Drug Shortage Report for DUREZOL
| Report ID | 250425 |
| Drug Identification Number | 02415534 |
| Brand name | DUREZOL |
| Common or Proper name | DUREZOL 0.05%EMUL 5ML |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DIFLUPREDNATE |
| Strength(s) | 0.05% |
| Dosage form(s) | EMULSION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 5ML |
| ATC code | S01BA |
| ATC description | ANTIINFLAMMATORY AGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2025-03-10 |
| Actual start date | 2025-03-20 |
| Estimated end date | 2025-04-25 |
| Actual end date | 2025-04-17 |
| Shortage status | Resolved |
| Updated date | 2025-04-18 |
| Company comments | Product on allocation to minimize patient impact |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v13 | 2025-04-18 | English | Compare |
| v12 | 2025-04-17 | French | Compare |
| v11 | 2025-04-17 | English | Compare |
| v10 | 2025-04-03 | French | Compare |
| v9 | 2025-04-03 | English | Compare |
| v8 | 2025-03-21 | English | Compare |
| v7 | 2025-03-20 | French | Compare |
| v6 | 2025-03-20 | English | Compare |
| v5 | 2025-03-11 | English | Compare |
| v4 | 2025-02-28 | French | Compare |
| v3 | 2025-02-28 | English | Compare |
| v2 | 2025-02-14 | French | Compare |
| v1 | 2025-02-14 | English | Compare |
Showing 1 to 13 of 13